Annual D&A
$527.00 K
+$60.00 K+12.85%
31 December 2023
Summary:
Madrigal Pharmaceuticals annual depreciation & amortization is currently $527.00 thousand, with the most recent change of +$60.00 thousand (+12.85%) on 31 December 2023. During the last 3 years, it has risen by +$56.00 thousand (+11.89%). MDGL annual D&A is now -85.58% below its all-time high of $3.65 million, reached on 31 December 2006.MDGL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$298.00 K
+$31.00 K+11.61%
30 September 2024
Summary:
Madrigal Pharmaceuticals quarterly depreciation & amortization is currently $298.00 thousand, with the most recent change of +$31.00 thousand (+11.61%) on 30 September 2024. Over the past year, it has increased by +$163.00 thousand (+120.74%). MDGL quarterly D&A is now -66.10% below its all-time high of $879.00 thousand, reached on 31 December 2007.MDGL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$875.00 K
+$163.00 K+22.89%
30 September 2024
Summary:
Madrigal Pharmaceuticals TTM depreciation & amortization is currently $875.00 thousand, with the most recent change of +$163.00 thousand (+22.89%) on 30 September 2024. Over the past year, it has increased by +$361.00 thousand (+70.23%). MDGL TTM D&A is now -73.89% below its all-time high of $3.35 million, reached on 31 December 2007.MDGL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDGL Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.8% | +120.7% | +70.2% |
| 3 y3 years | +11.9% | +207.2% | +110.8% |
| 5 y5 years | +449.0% | +964.3% | +702.8% |
MDGL Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +30.1% | at high | +207.2% | at high | +119.3% |
| 5 y | 5 years | at high | +449.0% | at high | +964.3% | at high | +702.8% |
| alltime | all time | -85.6% | -66.1% | +188.4% | -73.9% | +359.6% |
Madrigal Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $298.00 K(+11.6%) | $875.00 K(+22.9%) |
| June 2024 | - | $267.00 K(+58.9%) | $712.00 K(+24.7%) |
| Mar 2024 | - | $168.00 K(+18.3%) | $571.00 K(+8.3%) |
| Dec 2023 | $527.00 K(+12.8%) | $142.00 K(+5.2%) | $527.00 K(+2.5%) |
| Sept 2023 | - | $135.00 K(+7.1%) | $514.00 K(+2.8%) |
| June 2023 | - | $126.00 K(+1.6%) | $500.00 K(+3.3%) |
| Mar 2023 | - | $124.00 K(-3.9%) | $484.00 K(+3.6%) |
| Dec 2022 | $467.00 K(+15.3%) | $129.00 K(+6.6%) | $467.00 K(+5.2%) |
| Sept 2022 | - | $121.00 K(+10.0%) | $444.00 K(+5.7%) |
| June 2022 | - | $110.00 K(+2.8%) | $420.00 K(+5.3%) |
| Mar 2022 | - | $107.00 K(+0.9%) | $399.00 K(-1.5%) |
| Dec 2021 | $405.00 K(-14.0%) | $106.00 K(+9.3%) | $405.00 K(-2.4%) |
| Sept 2021 | - | $97.00 K(+9.0%) | $415.00 K(-4.2%) |
| June 2021 | - | $89.00 K(-21.2%) | $433.00 K(-5.7%) |
| Mar 2021 | - | $113.00 K(-2.6%) | $459.00 K(-2.5%) |
| Dec 2020 | $471.00 K(+320.5%) | $116.00 K(+0.9%) | $471.00 K(+23.0%) |
| Sept 2020 | - | $115.00 K(0.0%) | $383.00 K(+29.4%) |
| June 2020 | - | $115.00 K(-8.0%) | $296.00 K(+41.6%) |
| Mar 2020 | - | $125.00 K(+346.4%) | $209.00 K(+86.6%) |
| Dec 2019 | $112.00 K(+16.7%) | $28.00 K(0.0%) | $112.00 K(+2.8%) |
| Sept 2019 | - | $28.00 K(0.0%) | $109.00 K(+3.8%) |
| June 2019 | - | $28.00 K(0.0%) | $105.00 K(+4.0%) |
| Mar 2019 | - | $28.00 K(+12.0%) | $101.00 K(+5.2%) |
| Dec 2018 | $96.00 K(+24.7%) | $25.00 K(+4.2%) | $96.00 K(-26.7%) |
| Sept 2018 | - | $24.00 K(0.0%) | $131.00 K(+12.9%) |
| June 2018 | - | $24.00 K(+4.3%) | $116.00 K(+16.0%) |
| Mar 2018 | - | $23.00 K(-61.7%) | $100.00 K(+29.9%) |
| Dec 2017 | $77.00 K(>+9900.0%) | $60.00 K(+566.7%) | $77.00 K(+352.9%) |
| Sept 2017 | - | $9000.00(+12.5%) | $17.00 K(+112.5%) |
| June 2017 | - | $8000.00(>+9900.0%) | $8000.00(>+9900.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2016 | - | $0.00(0.0%) | -$337.00 K(<-9900.0%) |
| Dec 2015 | $0.00 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2015 | - | -$337.00 K(-300.6%) | $169.00 K(-74.9%) |
| June 2015 | - | $168.00 K(-0.6%) | $673.00 K(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $169.00 K(0.0%) | $674.00 K(+0.1%) |
| Dec 2014 | $673.00 K(+30.4%) | $169.00 K(+1.2%) | $673.00 K(+4.0%) |
| Sept 2014 | - | $167.00 K(-1.2%) | $647.00 K(+3.0%) |
| June 2014 | - | $169.00 K(+0.6%) | $628.00 K(+7.5%) |
| Mar 2014 | - | $168.00 K(+17.5%) | $584.00 K(+13.2%) |
| Dec 2013 | $516.00 K(-30.1%) | $143.00 K(-3.4%) | $516.00 K(+5.7%) |
| Sept 2013 | - | $148.00 K(+18.4%) | $488.00 K(-4.3%) |
| June 2013 | - | $125.00 K(+25.0%) | $510.00 K(-16.1%) |
| Mar 2013 | - | $100.00 K(-13.0%) | $608.00 K(-17.6%) |
| Dec 2012 | $738.00 K(-49.6%) | $115.00 K(-32.4%) | $738.00 K(-19.3%) |
| Sept 2012 | - | $170.00 K(-23.8%) | $914.00 K(-16.5%) |
| June 2012 | - | $223.00 K(-3.0%) | $1.09 M(-12.8%) |
| Mar 2012 | - | $230.00 K(-21.0%) | $1.25 M(-14.3%) |
| Dec 2011 | $1.46 M(-24.3%) | $291.00 K(-16.9%) | $1.46 M(-10.5%) |
| Sept 2011 | - | $350.00 K(-8.9%) | $1.64 M(-7.0%) |
| June 2011 | - | $384.00 K(-12.5%) | $1.76 M(-5.3%) |
| Mar 2011 | - | $439.00 K(-5.2%) | $1.86 M(-3.9%) |
| Dec 2010 | $1.93 M(-21.5%) | $463.00 K(-2.1%) | $1.93 M(-2.6%) |
| Sept 2010 | - | $473.00 K(-1.9%) | $1.99 M(-6.2%) |
| June 2010 | - | $482.00 K(-6.4%) | $2.12 M(-7.4%) |
| Mar 2010 | - | $515.00 K(0.0%) | $2.29 M(-7.2%) |
| Dec 2009 | $2.46 M(-9.3%) | $515.00 K(-14.7%) | $2.46 M(-6.3%) |
| Sept 2009 | - | $604.00 K(-7.2%) | $2.63 M(-4.5%) |
| June 2009 | - | $651.00 K(-6.1%) | $2.75 M(+0.8%) |
| Mar 2009 | - | $693.00 K(+1.6%) | $2.73 M(+0.6%) |
| Dec 2008 | $2.72 M(-18.9%) | $682.00 K(-6.4%) | $2.72 M(-6.8%) |
| Sept 2008 | - | $729.00 K(+16.1%) | $2.91 M(-3.2%) |
| June 2008 | - | $628.00 K(-7.4%) | $3.01 M(-6.8%) |
| Mar 2008 | - | $678.00 K(-22.9%) | $3.23 M(-3.6%) |
| Dec 2007 | $3.35 M(-8.3%) | $879.00 K(+6.4%) | $3.35 M(+35.6%) |
| Sept 2007 | - | $826.00 K(-2.6%) | $2.47 M(+50.2%) |
| June 2007 | - | $848.00 K(+6.3%) | $1.65 M(+106.3%) |
| Mar 2007 | - | $798.00 K(+85.6%) | $798.00 K(+85.6%) |
| Dec 2006 | $3.65 M(+48.9%) | - | - |
| Dec 2005 | $2.46 M(+58.7%) | - | - |
| Mar 2005 | - | $430.00 K | $430.00 K |
| Dec 2004 | $1.55 M(+53.8%) | - | - |
| Dec 2003 | $1.01 M | - | - |
FAQ
- What is Madrigal Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual D&A year-on-year change?
- What is Madrigal Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly D&A year-on-year change?
- What is Madrigal Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals TTM D&A year-on-year change?
What is Madrigal Pharmaceuticals annual depreciation & amortization?
The current annual D&A of MDGL is $527.00 K
What is the all time high annual D&A for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual depreciation & amortization is $3.65 M
What is Madrigal Pharmaceuticals annual D&A year-on-year change?
Over the past year, MDGL annual depreciation & amortization has changed by +$60.00 K (+12.85%)
What is Madrigal Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of MDGL is $298.00 K
What is the all time high quarterly D&A for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly depreciation & amortization is $879.00 K
What is Madrigal Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, MDGL quarterly depreciation & amortization has changed by +$163.00 K (+120.74%)
What is Madrigal Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of MDGL is $875.00 K
What is the all time high TTM D&A for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high TTM depreciation & amortization is $3.35 M
What is Madrigal Pharmaceuticals TTM D&A year-on-year change?
Over the past year, MDGL TTM depreciation & amortization has changed by +$361.00 K (+70.23%)